ARROWHEAD PHARMACEUTICALS, INC. Annual Earnings Per Share, Basic in USD/shares from 2010 to 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2010 to 2024.
  • Arrowhead Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -1.36 USD/shares, a 32% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -5 USD/shares, a 160% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2024 was -5 USD/shares, a 160% decline from 2023.
  • Arrowhead Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -1.92 USD/shares, a 15% decline from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -1.67 USD/shares, a 22.8% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$5 -$3 -160% Oct 1, 2023 Sep 30, 2024 10-K 2024-11-26
2023 -$2 $0 -15% Oct 1, 2022 Sep 30, 2023 10-K 2024-11-26
2022 -$2 $0 -22.8% Oct 1, 2021 Sep 30, 2022 10-K 2024-11-26
2021 -$1 -$1 -61.9% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-29
2020 -$1 -$2 -217% Oct 1, 2019 Sep 30, 2020 10-K 2022-11-28
2019 $0.72 +$1.37 Oct 1, 2018 Sep 30, 2019 10-K 2021-11-22
2018 -$1 $0 -38.3% Oct 1, 2017 Sep 30, 2018 10-K 2020-11-23
2017 $0 Oct 1, 2016 Sep 30, 2017 10-K 2019-11-25
2012 -$2 -$1 -332% Oct 1, 2011 Sep 30, 2012 10-K 2012-12-28
2011 $0 +$0.46 +51.1% Oct 1, 2010 Sep 30, 2011 10-K 2012-12-28
2010 -$1 Oct 1, 2009 Sep 30, 2010 10-K 2011-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.